Ken Griffin Gilead Sciences, Inc. Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 1,309,400 shares of GILD stock, worth $121 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,309,400

Previous 1,143,700 14.49%

Holding current value

$121 Million

Previous $78.5 Million 39.87%

% of portfolio

0.02%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$66.59 - $83.99 $316 Million - $398 Million	4,739,526 Added 1702.5%	5,017,913 $421 Million
Q2 2024 Aug 14, 2024	SELL	$63.15 - $72.88 $318 Million - $368 Million	-5,043,307 Reduced 94.77%	278,387 $19.1 Million
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $352 Million - $430 Million	4,920,490 Added 1226.43%	5,321,694 $390 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $680,531 - $771,739	9,288 Added 2.37%	401,204 $32.5 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $6.88 Million - $7.51 Million	93,050 Added 31.13%	391,916 $29.4 Million
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $148 Million - $169 Million	-1,952,853 Reduced 86.73%	298,866 $23 Million
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $46.1 Million - $52.6 Million	596,704 Added 36.05%	2,251,719 $187 Million
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $81.9 Million - $118 Million	1,313,568 Added 384.71%	1,655,015 $142 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $166 Million - $189 Million	-2,785,260 Reduced 89.08%	341,447 $21.1 Million
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $39.1 Million - $44 Million	677,470 Added 27.66%	3,126,707 $193 Million
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $103 Million - $130 Million	1,785,014 Added 268.74%	2,449,237 $146 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $17.4 Million - $19.7 Million	267,834 Added 67.57%	664,223 $48.2 Million
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $51.4 Million - $55.5 Million	-759,335 Reduced 65.7%	396,389 $27.7 Million
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $316 Million - $345 Million	-4,974,998 Reduced 81.15%	1,155,724 $79.6 Million
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $128 Million - $146 Million	2,130,066 Added 53.24%	6,130,722 $396 Million
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $65.6 Million - $74.7 Million	1,157,949 Added 40.73%	4,000,656 $233 Million
Q3 2020 Nov 16, 2020	BUY	$62.1 - $78.08 $63.6 Million - $80 Million	1,024,497 Added 56.35%	2,842,707 $180 Million
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $90.9 Million - $106 Million	1,256,637 Added 223.77%	1,818,210 $140 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $49.8 Million - $63.8 Million	-795,084 Reduced 58.61%	561,573 $42 Million
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $40 Million - $44 Million	-649,146 Reduced 32.36%	1,356,657 $88.2 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $45.1 Million - $49.7 Million	-720,956 Reduced 26.44%	2,005,803 $127 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $183 Million - $206 Million	-2,962,280 Reduced 52.07%	2,726,759 $184 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $154 Million - $172 Million	2,455,747 Added 75.95%	5,689,039 $0
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $9.36 Million - $12.2 Million	-154,589 Reduced 4.56%	3,233,292 $202 Million
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $30.8 Million - $34.1 Million	432,588 Added 14.64%	3,387,881 $0
Q2 2018 Aug 10, 2018	SELL	$64.88 - $75.68 $68.7 Million - $80.2 Million	-1,059,344 Reduced 26.39%	2,955,293 $0
Q1 2018 May 11, 2018	BUY	$72.84 - $88.8 $131 Million - $160 Million	1,804,792 Added 81.67%	4,014,637 $303 Million
Q4 2017 Feb 09, 2018	BUY	$71.15 - $83.52 $154 Million - $180 Million	2,160,605 Added 4387.91%	2,209,845 $158 Million
Q3 2017 Nov 09, 2017	BUY	$72.11 - $85.47 $3.55 Million - $4.21 Million	49,240	49,240 $3.99 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account